Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial
Movement Disorders · 2024
DOI: 10.1002/mds.29940 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Movement Disorders, 2024. Verfasst von Lukas L Goede und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Un…. Hauptthemen laut MEDLINE: Parkinson Disease, Transcranial Direct Current Stimulation, Cross-Over Studies. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Background
Recent imaging studies identified a brain network associated with clinical improvement following deep brain stimulation (DBS) in Parkinson's disease (PD), the PD response network.
Objectives
This study aimed to assess the impact of neuromodulation on PD motor symptoms by targeting this network noninvasively using multifocal transcranial direct current stimulation (tDCS).
Methods
In a prospective, randomized, double‐blinded, crossover trial, 21 PD patients (mean age 59.7 years, mean Hoehn & Yahr [H&Y] 2.4) received multifocal tDCS targeting the a‐priori network. Twenty‐minute sessions of tDCS and sham were administered on 2 days in randomized order. Movement Disorder Society‐Unified Parkinson's Disease Rating Scale—Part III (MDS‐UPDRS‐III) scores were assessed.
Results
Before intervention, MDS‐UPDRS‐III scores were comparable in both conditions (stimulation days: 37.38 (standard deviation [SD] = 12.50, confidence interval [CI] = 32.04, 42.73) vs. sham days: 36.95 (SD = 13.94, CI = 30.99, 42.91), P = 0.63). Active stimulation resulted in a reduction by 3.6 points (9.7%) to 33.76 (SD = 11.19, CI = 28.98, 38.55) points, whereas no relevant change was observed after sham stimulation (36.43 [SD = 14.15, CI = 30.38, 42.48], average improvement: 0.5 [1.4%]). Repeated‐measures analysis of variance (ANOVA) confirmed significance (main effect of time: F (1,20) =4.35, P < 0.05). Tukey's post hoc tests indicated MDS‐UPDRS‐III improvement after active stimulation ( t [20] = 2.9, P = 0.03) but not after sham ( t [20] = 0.42, P > 0.05). In a subset of patients that underwent DBS surgery later, their DBS response correlated with tDCS effects ( R = 0.55, P (1) = 0.04).
Conclusion
Noninvasive, multifocal tDCS targeting a DBS‐derived network significantly improved PD motor symptoms. Despite a small effect size, this study provides proof of principle for the successful noninvasive neuromodulation of an invasively identified network. Future studies should investigate repeated tDCS sessions and their utility for screening before DBS surgery. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- BIH Biomedical Innovation Academy, BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Center for Brain Circuit Therapeutics, Department of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Bernstein Center for Computational Neuroscience, Humboldt-Universität, Berlin, Germany.
- NeuroCure, Exzellenzcluster, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany.
ORCID-Profile: Lukas L Goede, Daniel Kroneberg, Patricia Krause, Roxanne Lofredi
Förderung
- NIH HHS
- NINDS NIH HHS
- NIMH NIH HHS
- Deutsche Forschungsgemeinschaft
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Goede, L. L., Oxenford, S., Kroneberg, D., Meyer, G. M., Rajamani, N., Neudorfer, C., Krause, P., Lofredi, R., Fox, M. D., Kühn, A. A., & Horn, A. (2024). Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial. Movement Disorders. https://doi.org/10.1002/mds.29940
Vancouver
Goede LL, Oxenford S, Kroneberg D, Meyer GM, Rajamani N, Neudorfer C, et al. Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial. Movement Disorders. 2024. doi:10.1002/mds.29940
BibTeX
@article{Goede2024,
author = {Goede, Lukas L and Oxenford, Simon and Kroneberg, Daniel and Meyer, Garance M and Rajamani, Nanditha and Neudorfer, Clemens and Krause, Patricia and Lofredi, Roxanne and Fox, Michael D and Kühn, Andrea A and Horn, Andreas},
title = {Linking Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: A Randomized Trial},
journal = {Movement Disorders},
year = {2024},
doi = {10.1002/mds.29940}
}
EUVIMED